(1)
Benefits and Risks of Testosterone Treatment for Hypoactive Sexual Desire Disorder in Women: A Critical Review of Studies Published in the Decades Preceding and Succeeding the Advent of Phosphodiesterase Type 5 Inhibitors. Clinics 2014, 69 (4), 294-303. https://doi.org/10.1590/clin.v69i4.79512.